Physician profile
Suresh Koneru
NPI 1972503092
$16,766.27
in general payments reported to CMS, 2019-2025
20 companies · $1,350 in 2025
The $1,350 reported for 2025 was more than what 80% of Surgery of The Hand (Plastic Surgery) providers received nationally (typical 2025 total: $312).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $11K · 2020: $70.81 · 2021: $379 · 2022: $2,097 · 2023: $1,698 · 2024: $407 · 2025: $1,350.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Travel and Lodging: $1,735 · Food and Beverage: $1,719.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Travel and Lodging | $1,734.62 |
| Food and Beverage | $1,719.28 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kci USA, INC. | $12,042.41 | 2019-2022 | |
| Musculoskeletal Transplant Foundation INC. | $2,565.06 | 2023-2025 | |
| Mentor Worldwide LLC | $481.35 | 2021-2024 | Mentor Memorygel Resterilizable Gel Sizer |
| Tela Bio, INC. | $343.87 | 2023-2025 | Ovitex Reinforced Bioscaffold With Permanent Polymer (Ovitex), Ovitex 2s |
| Sientra, INC. | $190.50 | 2022 | |
| Bard Peripheral Vascular, INC. | $189.44 | 2021 | |
| Davol INC. | $177.61 | 2022 | |
| Organogenesis INC. | $147.60 | 2019-2022 | |
| Allergan, INC. | $145.47 | 2022 | |
| Heron Therapeutics, INC. | $125.00 | 2025 | Zynrelef |
| Acelrx Pharmaceuticals, INC. | $74.21 | 2021 | |
| Kerecis Limited | $55.59 | 2019-2020 | |
| Tepha INC | $51.86 | 2019 | |
| Galderma Laboratories, L.P. | $45.59 | 2023-2024 | |
| Pacira Pharmaceuticals Incorporated | $31.54 | 2019 |
Show all 20 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Aroa Biosurgery Incorporated | $27.29 | 2025 | |
| Integra Lifesciences Corporation | $21.09 | 2023 | Durasorb Monofilament Mesh |
| Smith+Nephew, INC. | $19.44 | 2020 | |
| Merz North America, INC. | $17.88 | 2023 | |
| Abbvie INC. | $13.47 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Suresh Koneru listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.